The Coca-Cola Company is recalling certain Minute Maid products due to the possibility of containing foreign objects, such as metal bolts or washers.
According to the US Food and Drug Administration, the recalled products were distributed in Connecticut, Maine, Maryland, New York, North Carolina, New Jersey, Pennsylvania, and Virginia.
Since the products expire in 2022, there is concern that many consumers may still have the products in their homes because of their long shelf life.
The recall of Minute Maid is Coca-Cola’s most recent following a similar action in late November concerning Coca-Cola and Sprite sodas in cans containing an undisclosed foreign matter.
Like the recalled Minute Maid products, the Coca-Cola and Sprite sodas in cans also expire in 2022.
Coca-Cola sold the recalled Coke and Sprite products across Southeastern states.


South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Instagram Outage Disrupts Thousands of U.S. Users
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



